Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
  • Payor
Campus
  • Payor

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Resources

Resources

TTP is a life-threatening thrombotic microangiopathy (TMA) that requires quick diagnosis and urgent treatment. 1,2

Learn more
Multiple Myeloma: Elderly Patients

Multiple Myeloma: Elderly Patients

Learn more
Multiple Myeloma: High Risk Cytogenetics

Multiple Myeloma: High Risk Cytogenetics

Learn more
Multiple Myeloma: Renal Impairment

Multiple Myeloma: Renal Impairment

Learn more
Lenalidomide Refractory Patients

Lenalidomide Refractory Patients

Learn more
Multiple Myeloma: Minimal Residual Disease

Multiple Myeloma: Minimal Residual Disease

Learn more
Multiple Myeloma: Chromosome 1q+ cytogenetic abnormalities

Multiple Myeloma: Chromosome 1q+ cytogenetic abnormalities

Learn more
Diagnostic Algorithm for Gaucher Disease in Adult

Diagnostic Algorithm for Gaucher Disease in Adult

Learn more
Diagnostic Algorithm for Gaucher Disease in Pediatric

Diagnostic Algorithm for Gaucher Disease in Pediatric

Learn more
Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Learn more
Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease for orthopedists

Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease for orthopedists

Learn more
Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease (LOPD)

Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease (LOPD)

Learn more